About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Depression Clinical Trials in Houston | 165 Studies

Clinical Trials DepressionHouston

Depression Clinical Trials in Houston

Find 165 clinical trials for depression near Houston, Texas. Connect with research centers in your area.

All Depression trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 165 trials

CompletedA Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)This is a Phase 3, open-label, 1-year study of the safety, tolerability, and need for re-treatment with SAGE-217 in adult participants with MDD.NCT03864614·Dothan, Alabama and 51 others

Depression Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive DisorderThis is a Phase 2 clinical study evaluating the safety and effectiveness of SP-624 as compared to placebo in the treatment of adults with Major Depressive Disorder.NCT04479852·Phoenix, Arizona and 38 others

TerminatedEfficacy and Safety Study of ABT-436 in Major Depressive DisorderThe purpose is to study the efficacy and safety of ABT-436 in Major Depressive Disorder.NCT01741142·Little Rock, Arkansas and 17 others

CompletedPRIME Care (PRecision Medicine In MEntal Health Care)The focus of this application is on the impact of providing depressed Veterans and their providers with the results of pharmacogenetic (PGx) testing for psychotropic medications.NCT03170362·North Little Rock, Arkansas and 23 others

CompletedEfficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive DisorderThe study will assess efficacy, safety and tolerability of 0.5 mg/day and 1 mg/day of sublingual (under the tongue) formulation of agomelatine in patients with Major Depressive…NCT01110889·Birmingham, Alabama and 47 others

CompletedA Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive DisorderTo evaluate the efficacy and safety of AXS-05 relative to bupropion in subjects with treatment resistant major depressive disorder (MDD).NCT02741791·Phoenix, Arizona and 73 others

CompletedA Study in the Treatment of Children and Adolescents With Major Depressive DisorderThe purpose of this study is to assess whether duloxetine is superior to placebo in the treatment of children and adolescents with major depressive disorder (MDD)NCT00849693·Birmingham, Alabama and 55 others

CompletedStudy of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive DisorderThe purpose of this study is to assess the long-term safety, tolerability and efficacy of oral OPC-34712 as adjunctive therapy in the treatment of adult patients with Major…NCT01447576·Arcadia, California and 31 others

CompletedEfficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)The objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDDNCT01715805·Tucson, Arizona and 84 others

CompletedSafety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive DisorderThe purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone relative to placebo in adolescent outpatients (12-17) with major depressive disorder.NCT01878292·Imperial, California and 51 others

CompletedA Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 StudyThis study will evaluate the efficacy and safety of ALKS 5461.NCT02158546·Little Rock, Arkansas and 57 others

CompletedEfficacy and Tolerability of Riluzole in Treatment Resistant DepressionThis study aims to examine the antidepressant efficacy of riluzole, employing a randomized, double-blind, placebo-controlled, adjunctive trial in treatment-resistant major…NCT01204918·New Haven, Connecticut and 2 others

CompletedA Safety, Efficacy and Tolerability Study of SEP-225289To determine the safety, efficacy and tolerability of SEP-225289 in subjects with Major Depressive DisorderNCT00584974·Little Rock, Arkansas and 50 others

CompletedAdaptive Design Study of NEST sTMS in Subjects With Major Depressive DisorderThis is a double-blind, sham controlled, multi-center study to confirm the safety and efficacy of synchronized transcranial magnetic stimulation (sTMS) for the treatment of…NCT03288714·La Jolla, California and 13 others

TerminatedA Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive DisorderThe purpose of this study is to evaluate the effectiveness and safety of JNJ26489112 compared with an active control (Venlafaxine XR) and placebo in patients with…NCT01114698·Arcadia, California and 13 others

CompletedLong-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000, in participants with Major Depressive Disorder (MDD).NCT06423781·Chandler, Arizona and 65 others

CompletedStudy to Evaluate Efficacy and Safety of Ropanicant in MDD PatientsThe primary objective is to evaluate the efficacy of Ropanicant at two different dosage levels compared to placebo in patients with Major Depressive Disorder (MDD).NCT06836063·Little Rock, Arkansas and 34 others

TerminatedSafety and Efficacy of EVT 101 in Treatment-Resistant DepressionThis study is a 4-week, randomized, double-blind, parallel-group, placebo-controlled monotherapy study in patients with treatment-resistant major depression.NCT01128452·Oceanside, California and 13 others

CompletedARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant TreatmentThis multi-center, randomized, double-blind, placebo-controlled, parallel-group study will investigate the efficacy and safety of RO4995819 as adjunctive therapy in patients with…NCT01457677·Phoenix, Arizona and 91 others

CompletedStudy to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDDTo evaluate the efficacy of NBI-1065846 compared with placebo on improving symptoms of anhedonia in participants with major depressive disorder (MDD).NCT05165394·Birmingham, Alabama and 22 others

PreviousPage 3 of 9Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia